These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33425926)

  • 1. Determining the Fate of Neurons in SCA3: ATX3, a Rising Decision Maker in Response to DNA Stresses and Beyond.
    Tu Y; Li X; Zhu X; Liu X; Guo C; Jia D; Tang TS
    Front Cell Dev Biol; 2020; 8():619911. PubMed ID: 33425926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward therapeutic targets for SCA3: Insight into the role of Machado-Joseph disease protein ataxin-3 in misfolded proteins clearance.
    Li X; Liu H; Fischhaber PL; Tang TS
    Prog Neurobiol; 2015 Sep; 132():34-58. PubMed ID: 26123252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease.
    Matos CA; de Macedo-Ribeiro S; Carvalho AL
    Prog Neurobiol; 2011 Sep; 95(1):26-48. PubMed ID: 21740957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FipoQ/FBXO33, a Cullin-1-based ubiquitin ligase complex component modulates ubiquitination and solubility of polyglutamine disease protein.
    Chen ZS; Wong AKY; Cheng TC; Koon AC; Chan HYE
    J Neurochem; 2019 Jun; 149(6):781-798. PubMed ID: 30685895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic prospects for spinocerebellar ataxia type 2 and 3.
    Bezprozvanny I; Klockgether T
    Drugs Future; 2009 Dec; 34(12):. PubMed ID: 26023252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of NF-κB in astrocytes is sufficient to delay neurodegeneration induced by proteotoxicity in neurons.
    Li YX; Sibon OCM; Dijkers PF
    J Neuroinflammation; 2018 Sep; 15(1):261. PubMed ID: 30205834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T1-11 and JMF1907 ameliorate polyglutamine-expanded ataxin-3-induced neurodegeneration, transcriptional dysregulation and ataxic symptom in the SCA3 transgenic mouse.
    Chou AH; Chen YL; Chiu CC; Yuan SJ; Weng YH; Yeh TH; Lin YL; Fang JM; Wang HL
    Neuropharmacology; 2015 Dec; 99():308-17. PubMed ID: 26254860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H1152 promotes the degradation of polyglutamine-expanded ataxin-3 or ataxin-7 independently of its ROCK-inhibiting effect and ameliorates mutant ataxin-3-induced neurodegeneration in the SCA3 transgenic mouse.
    Wang HL; Hu SH; Chou AH; Wang SS; Weng YH; Yeh TH
    Neuropharmacology; 2013 Jul; 70():1-11. PubMed ID: 23347954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeic acid and resveratrol ameliorate cellular damage in cell and Drosophila models of spinocerebellar ataxia type 3 through upregulation of Nrf2 pathway.
    Wu YL; Chang JC; Lin WY; Li CC; Hsieh M; Chen HW; Wang TS; Wu WT; Liu CS; Liu KL
    Free Radic Biol Med; 2018 Feb; 115():309-317. PubMed ID: 29247688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy and Polyglutamine Disease.
    Ren H; Hao Z; Wang G
    Adv Exp Med Biol; 2020; 1207():149-161. PubMed ID: 32671744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different ataxin-3 amyloid aggregates induce intracellular Ca(2+) deregulation by different mechanisms in cerebellar granule cells.
    Pellistri F; Bucciantini M; Invernizzi G; Gatta E; Penco A; Frana AM; Nosi D; Relini A; Regonesi ME; Gliozzi A; Tortora P; Robello M; Stefani M
    Biochim Biophys Acta; 2013 Dec; 1833(12):3155-3165. PubMed ID: 24035922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SUMOylation of the brain-predominant Ataxin-3 isoform modulates its interaction with p97.
    Almeida B; Abreu IA; Matos CA; Fraga JS; Fernandes S; Macedo MG; Gutiérrez-Gallego R; Pereira PJ; Carvalho AL; Macedo-Ribeiro S
    Biochim Biophys Acta; 2015 Sep; 1852(9):1950-9. PubMed ID: 26073430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein.
    Ashraf NS; Sutton JR; Yang Y; Ranxhi B; Libohova K; Shaw ED; Barget AJ; Todi SV; Paulson HL; Costa MDC
    Neurobiol Dis; 2020 Apr; 137():104697. PubMed ID: 31783119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
    Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
    Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAN Translation of the Expanded CAG Repeats in the SCA3 Disease Context.
    Jazurek-Ciesiolka M; Ciesiolka A; Komur AA; Urbanek-Trzeciak MO; Krzyzosiak WJ; Fiszer A
    J Mol Biol; 2020 Dec; 432(24):166699. PubMed ID: 33157084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyglutamine expansion of ataxin-3 alters its degree of ubiquitination and phosphorylation at specific sites.
    Kristensen LV; Oppermann FS; Rauen MJ; Hartmann-Petersen R; Thirstrup K
    Neurochem Int; 2017 May; 105():42-50. PubMed ID: 28065793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyglutamine tracts regulate beclin 1-dependent autophagy.
    Ashkenazi A; Bento CF; Ricketts T; Vicinanza M; Siddiqi F; Pavel M; Squitieri F; Hardenberg MC; Imarisio S; Menzies FM; Rubinsztein DC
    Nature; 2017 May; 545(7652):108-111. PubMed ID: 28445460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fructose-2,6-bisphosphate restores DNA repair activity of PNKP and ameliorates neurodegenerative symptoms in Huntington's disease.
    Chakraborty A; Sreenivasmurthy SG; Miller W; Huai W; Biswas T; Mandal SM; Boscá L; Krishnan B; Ghosh G; Hazra T
    bioRxiv; 2024 Jul; ():. PubMed ID: 37961108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional Dysregulation and Post-translational Modifications in Polyglutamine Diseases: From Pathogenesis to Potential Therapeutic Strategies.
    Xiang C; Zhang S; Dong X; Ma S; Cong S
    Front Mol Neurosci; 2018; 11():153. PubMed ID: 29867345
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.